Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
Breast cancer diagnostic development program launched
January 5th, 2006
Ciphergen Biosystems, Inc., (CIPHE) announced it is launching a formal breast cancer diagnostic development program based on a series of discoveries made using Ciphergen's surface enhanced laser desorption/ionization (SELDI) technology and PatternTrack biomarker discovery process. The original study by Li (Clinical Chemistry 48(8) 1296-1304) published in 2002 detailed the discovery of three serum biomarkers that can improve detection of breast cancer. Two of the three markers have been identified and validated by two studies published recently. In the first study, Li, et al. (Clinical Chemistry 51 (2229-2235)) reported validation and identification of...
Source: Women's Health Weekly (2006-01-05)
|
